STOCK TITAN

[Form 4] Genasys Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Genasys Inc. director W. Craig Fugate received 6,411 shares of the company's common stock on 10/01/2025 as payment in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025. After the grant, Mr. Fugate beneficially owns 68,201 shares. The shares were valued by dividing the cash retainer by the closing price on the grant date; the transaction was reported on Form 4 and signed by an attorney-in-fact on 10/03/2025.

Il direttore di Genasys Inc., W. Craig Fugate, ha ricevuto 6,411 azioni ordinarie della società il 10/01/2025 come pagamento in luogo di un rateo contante maturato per il terzo e il quarto trimestre dell'esercizio 2025. Dopo l'assegnazione, il signor Fugate detiene beneficiariamente 68,201 azioni. Le azioni sono state valutate dividendo il rateo contante per il prezzo di chiusura nel giorno dell'assegnazione; la transazione è stata riportata nel Modulo 4 e firmata da un procuratore-in-fatto il 10/03/2025.
El director de Genasys Inc., W. Craig Fugate, recibió 6,411 acciones ordinarias de la empresa el 10/01/2025 como pago en lugar de un anticipo en efectivo acumulado para el tercer y cuarto trimestre del ejercicio 2025. Después de la concesión, el señor Fugate posee beneficiosamente 68,201 acciones. Las acciones se valoraron dividiendo el anticipo en efectivo por el precio de cierre en la fecha de la concesión; la operación fue reportada en el Formulario 4 y firmada por un apoderado en 10/03/2025.
Genasys Inc.의 이사 W. Craig Fugate가 2025 회계연도 제3분기 및 제4분기에 발생한 현금 수령 대신 보상으로 회사 보통주 6,411주를 10/01/2025에 받았습니다. 수여 후 Fugate 이사는 실질적으로 68,201주를 소유합니다. 주식은 수령일의 종가로 현금 수령액을 나눠 산정되었으며; 이 거래는 Form 4에 보고되었고 10/03/2025에 대리인이 서명했습니다.
Le directeur de Genasys Inc., W. Craig Fugate, a reçu 6,411 actions ordinaires de la société le 10/01/2025 en paiement au lieu d'un acompte en espèces accumulé pour le troisième et le quatrième trimestre de l'exercice 2025. Après l'attribution, M. Fugate détient bénéficiairement 68,201 actions. Les actions ont été évaluées en divisant l'acompte en espèces par le cours de clôture à la date d'attribution; la transaction a été déclarée sur le formulaire 4 et signée par un mandataire le 10/03/2025.
Der Vorstand von Genasys Inc., W. Craig Fugate, erhielt 6,411 Aktien der Stammaktien des Unternehmens am 10/01/2025 als Zahlung statt einer aufgelaufenen Barvergütung für das dritte und vierte Quartal des Geschäftsjahres 2025. Nach der Gewährung besitzt Herr Fugate wirtschaftlich 68,201 Aktien. Die Aktien wurden bewertet, indem die Barvergütung durch den Schlusskurs am Tag der Gewährung geteilt wurde; die Transaktion wurde in Form 4 gemeldet und von einem Bevollmächtigten am 10/03/2025 unterzeichnet.
مدير شركة Genasys Inc., W. Craig Fugate، تلقى 6,411 سهماً عادياً في الشركة في 10/01/2025 كتعويض بدلاً من بدلة نقدية متراكمة للربعين الثالث والرابع من السنة المالية 2025. بعد المنحة، يمتلك السيد Fugate بشكل مستفيد 68,201 سهماً. تم تقييم الأسهم من خلال تقسيم بدل النقد على سعر الإغلاق في يوم المنحة؛ وقد تم الإبلاغ عن الصفقة في النموذج 4 وتوقيعها من قبل وكيل قانوني في 10/03/2025.
Genasys Inc. 的董事 W. Craig Fugate 收到公司普通股 6,411 股,日期为 10/01/2025,作为第三季度和第四季度至2025财年的累计现金酬金的代替支付。授予后,Fugate 先生受益拥有 68,201 股。股票的估值方法是用现金酬金除以授予日的收盘价;该交易在表格 Form 4 上披露,并由代理人于 10/03/2025 签署。
Positive
  • None.
Negative
  • None.
Il direttore di Genasys Inc., W. Craig Fugate, ha ricevuto 6,411 azioni ordinarie della società il 10/01/2025 come pagamento in luogo di un rateo contante maturato per il terzo e il quarto trimestre dell'esercizio 2025. Dopo l'assegnazione, il signor Fugate detiene beneficiariamente 68,201 azioni. Le azioni sono state valutate dividendo il rateo contante per il prezzo di chiusura nel giorno dell'assegnazione; la transazione è stata riportata nel Modulo 4 e firmata da un procuratore-in-fatto il 10/03/2025.
El director de Genasys Inc., W. Craig Fugate, recibió 6,411 acciones ordinarias de la empresa el 10/01/2025 como pago en lugar de un anticipo en efectivo acumulado para el tercer y cuarto trimestre del ejercicio 2025. Después de la concesión, el señor Fugate posee beneficiosamente 68,201 acciones. Las acciones se valoraron dividiendo el anticipo en efectivo por el precio de cierre en la fecha de la concesión; la operación fue reportada en el Formulario 4 y firmada por un apoderado en 10/03/2025.
Genasys Inc.의 이사 W. Craig Fugate가 2025 회계연도 제3분기 및 제4분기에 발생한 현금 수령 대신 보상으로 회사 보통주 6,411주를 10/01/2025에 받았습니다. 수여 후 Fugate 이사는 실질적으로 68,201주를 소유합니다. 주식은 수령일의 종가로 현금 수령액을 나눠 산정되었으며; 이 거래는 Form 4에 보고되었고 10/03/2025에 대리인이 서명했습니다.
Le directeur de Genasys Inc., W. Craig Fugate, a reçu 6,411 actions ordinaires de la société le 10/01/2025 en paiement au lieu d'un acompte en espèces accumulé pour le troisième et le quatrième trimestre de l'exercice 2025. Après l'attribution, M. Fugate détient bénéficiairement 68,201 actions. Les actions ont été évaluées en divisant l'acompte en espèces par le cours de clôture à la date d'attribution; la transaction a été déclarée sur le formulaire 4 et signée par un mandataire le 10/03/2025.
Der Vorstand von Genasys Inc., W. Craig Fugate, erhielt 6,411 Aktien der Stammaktien des Unternehmens am 10/01/2025 als Zahlung statt einer aufgelaufenen Barvergütung für das dritte und vierte Quartal des Geschäftsjahres 2025. Nach der Gewährung besitzt Herr Fugate wirtschaftlich 68,201 Aktien. Die Aktien wurden bewertet, indem die Barvergütung durch den Schlusskurs am Tag der Gewährung geteilt wurde; die Transaktion wurde in Form 4 gemeldet und von einem Bevollmächtigten am 10/03/2025 unterzeichnet.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Fugate William Craig

(Last) (First) (Middle)
16262 WEST BERNARDO DRIVE

(Street)
SAN DIEGO CA 92127

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Genasys Inc. [ GNSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A(1) 6,411 A $0 68,201 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.
/s/ Cassandra Monteon as attorney-in-fact for W. Craig Fugate 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the GNSS Form 4 filed by W. Craig Fugate report?

The Form 4 reports a grant of 6,411 common shares to director W. Craig Fugate on 10/01/2025, issued in lieu of an accrued cash retainer.

How many GNSS shares does W. Craig Fugate own after the transaction?

Following the reported transaction, Mr. Fugate beneficially owns 68,201 shares of Genasys common stock.

Why were the 6,411 GNSS shares issued to the director?

The shares were granted in lieu of an accrued cash retainer for the third and fourth quarters of fiscal 2025, with the number determined by the cash value divided by the closing stock price on the grant date.

When was the Form 4 for this GNSS transaction signed and filed?

The Form 4 shows an authorized signature by an attorney-in-fact on 10/03/2025 and lists the transaction date as 10/01/2025.

Did the Form 4 disclose any option exercises or derivative transactions for GNSS?

No. The Form 4 discloses only a non-derivative grant of 6,411 common shares; no derivative securities were reported.
Genasys Inc

NASDAQ:GNSS

GNSS Rankings

GNSS Latest News

GNSS Latest SEC Filings

GNSS Stock Data

105.66M
41.78M
7.47%
54.52%
1.39%
Scientific & Technical Instruments
Household Audio & Video Equipment
Link
United States
SAN DIEGO